Photolitec (United States)

Recent papers from Photolitec (United States)

1. Anticancer Efficacy of HPPH-PDT Synergies with BCG-Immunotherapy or COX-2 Inhibitor in Treating Bladder CancerMolecular Pharmaceutics · 2026
2. Photobac derived from bacteriochlorophyll-a shows potential for treating brain tumor in animal models by photodynamic therapy with desired pharmacokinetics and limited toxicity in rats and dogsBiomedicine & Pharmacotherapy · 2023
3. Photodynamic Therapy in Combination with Doxorubicin Is Superior to Monotherapy for the Treatment of Lung CancerBiomedicines · 2022
4. Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of CancerJournal of Medicinal Chemistry · 2021
5. Sonodynamic therapy in combination with photodynamic therapy shows enhanced long-term cure of brain tumorScientific Reports · 2020
6. Targeted Nanoparticles for Fluorescence Imaging of Folate Receptor Positive TumorsBiomolecules · 2020
7. Pluronic F‐127: An Efficient Delivery Vehicle for 3‐(1'‐hexyloxy)ethyl‐3‐devinylpyropheophorbide‐a (HPPH or Photochlor)Photochemistry and Photobiology · 2019
8. Phototriggered Release of Tumor-Imaging and Therapy Agents from Lyophilized Multifunctional Polyacrylamide NanoparticlesACS Applied Bio Materials · 2019
9. Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic TherapyJournal of Medicinal Chemistry · 2019
10. Highly Effective Dual-Function Near-Infrared (NIR) Photosensitizer for Fluorescence Imaging and Photodynamic Therapy (PDT) of CancerJournal of Medicinal Chemistry · 2016